Improving Drug Price Transparency at the Point of Care

Created by 
American Medical Association (AMA)
Expired
Improving Drug Price Transparency at the Point of Care

Due to the lack of transparency of drug prices, physicians often prescribe medications with little to no information about how much the drug will cost their patient. Increased awareness could result in better treatment decision-making and ultimately, improved medication adherence and outcomes for patients. In this discussion, we’ll explore current availability and accessibility of EHR, pharmacy and payer functionalities that support transparency, where barriers exist, and what can be or is currently being done to address these barriers.

Stacy Lloyd
Celine Witherell
2
Moderators
Sharon Orrange
Trisha Flanagan
Michael Ganio
14
Experts